- Direction
- Inflecting
- Own history
- —
- Peers
- 83th
- Persistence
- REVERSING
· Services-Medical Laboratories
RESEARCH SNAPSHOTCareDx, Inc.'s latest supported as-filed period reports revenue of $139.4M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 1.16% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 9.13% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 39.29% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 6.56% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value 5.82% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 15.30% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 447.8%; Operating cash flow increased 209.3%.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 52.2%; Operating margin moved 9864 bp higher; Operating income changed across a sign change.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 39.3%; Operating margin moved 607 bp higher; Operating income changed across a sign change.
3 evidence-backed componentsInventory changed -75.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
CDNA · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001217234-26-000061SEC ↗8-KOct 29, 2026Period Oct 29, 20260001217234-26-000059SEC ↗4Oct 5, 2026Period Oct 1, 20260002019976-26-000011SEC ↗4Oct 5, 2026Period Oct 1, 20260001781127-26-000013SEC ↗4Oct 5, 2026Period Oct 1, 20260001543503-26-000007SEC ↗4Oct 5, 2026Period Oct 1, 20260002036499-26-000007SEC ↗4Oct 5, 2026Period Oct 2, 20260001366412-26-000008SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Oct 2, 2026Filed Oct 5, 2026 | Goldberg MichaelDirector | Grant Or AwardDirect | 588 | $0 | $0 | Form 4 ↗ |
| Oct 1, 2026Filed Oct 5, 2026 | Meng JessicaChief Commercial Officer | Tax WithholdingDirect | 2,619 | $66 | $173,456 | Form 4 ↗ |
| Oct 1, 2026Filed Oct 5, 2026 | Novack Jeffrey AdamSecretary and General Counsel | Tax WithholdingDirect | 997 | $66 | $66,031 | Form 4 ↗ |
| Sep 12, 2026Filed Sep 15, 2026 | Kennedy KeithCFO & COO | Tax WithholdingDirect | 8,220 | $52 | $430,481 | Form 4 ↗ |
| Aug 5, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value 6.93% · OPTIONAL
Current assets changed +39.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed +56.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +40.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed -49.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +48.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +38.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001217234-26-000052| Bickerstaff GeorgeDirector |
| Open Market SaleDirect |
| 20,000 |
| $46 |
| $925,700 |
| Form 4 ↗ |